title: Modulation of chromatic difference in receptive field size of H1 horizontal cells in carp retina: dopamine- and APB-sensitive mechanisms.
abstract: Chromatic aspects of receptive field size in the H1 horizontal cell syncytium of the carp retina were investigated using spectral photostimuli (blue or red) presented in the form of either a pair of a small spot and annulus, or a narrow moving slit. In the light-adapted retina, the receptive field for the blue stimulus was found to be significantly smaller than that for the red, i.e. there was a chromatic difference in the receptive field size. During the course of dark adaptation, the overall receptive field size increased, but the chromatic difference decreased. Immediately after adaptation to bright light, the receptive field sizes were reduced significantly, but the chromatic difference increased, mainly due to a greater reduction in the receptive field for the blue stimulus. Application of dopamine (5 microM) to a dark-adapted retina gradually decreased the receptive field size for both colours, but the chromatic difference became larger, again due to a greater reduction in the receptive field size for the blue stimulus. 2-Amino-4-phosphonobutyrate (APB) applied to light-adapted retinae at a working concentration of 1 mM, greatly expanded the receptive field size and suppressed the chromatic difference due to the effect being greater for the receptive field for the blue stimulus. The effect of APB was slow and cumulative. On the other hand, intracellular injection of cGMP or dibutyryl-cGMP increased the chromatic difference in the receptive field size. It is suggested (i) that the chromatic difference in the receptive field size could be due to a cGMP-coupled, conductance-decreasing receptor mechanism activated by APB; and (ii) that the mechanism is associated with short-wavelength sensitive cone input to the H1 cells and operates in the light-adapted state of the retina.
authors.affiliation: Department of Biology, Imperial College of Science, Technology and Medicine, London, UK. m.djamgoz@ic.ac.uk
authors.forename: M B
authors.initials: MB
authors.lastname: Djamgoz
authors.forename: R
authors.initials: R
authors.lastname: Petruv
authors.forename: S
authors.initials: S
authors.lastname: Yasui
authors.forename: T
authors.initials: T
authors.lastname: Furukawa
authors.forename: M
authors.initials: M
authors.lastname: Yamada
mesh_terms: D000221:Adaptation, Ocular; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D002347:Carps; D003118:Color Perception / Q000187:drug effects / Q000502:physiology*; D006152:Cyclic GMP / Q000494:pharmacology; D003624:Darkness; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D066298:In Vitro Techniques; D008027:Light; D009474:Neurons / Q000166:cytology / Q000502:physiology*; D012044:Regression Analysis; D012160:Retina / Q000166:cytology / Q000502:physiology* / Q000528:radiation effects; D014794:Visual Fields / Q000187:drug effects / Q000502:physiology*
chemical_list: D000613:Aminobutyrates; D018690:Excitatory Amino Acid Agonists; D003995:Dibutyryl Cyclic GMP; D006152:Cyclic GMP; C012729:2-amino-4-phosphonobutyric acid; D004298:Dopamine